CG Oncology, Inc. (CGON) Tops Q3 EPS by 12c

CG Oncology, Inc. (NASDAQ: CGON) reported Q3 EPS of ($0.30), $0.12 better than the analyst estimate of ($0.42).

For earnings history and earnings-related data on CG Oncology, Inc. (CGON) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
• TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance